Etminan et al examine the association between isotretinoin and the risk for inflammatory bowel disease (IBD) among women in a case-control study of a health claims database and a meta-analysis of previous studies. See also the editorial by Popescu and Bigby.
Weitz et al report 7 cases of contact dermatitis at the site of central access catheters treated with chlorhexidine gluconate–impregnated dressings.
Thornsberry and English retrospectively reviewed the medical records of 15 women with scalp dysesthesia and cervical spine images. A gabapentin regimen (topical or oral) had been recommended to 14 patients, 7 of whom had follow-up data.
Fajgenbaum et al report a case of eruptive cherry hemangiomatosis (ECH) the heralding sign of multicentric Castleman disease that occurred in a 25-year-old man with a 10-year history of benign vascular growths. The authors propose a possible mechanism and suggest that patients presenting with eruptive cherry hemangiomatosis (ECH) in the setting of systemic symptoms, should be fully evaluated for the potential development of multicentric Castleman disease and other lymphoproliferative diseases.
Geusau and colleagues diagnosed a patient as having features of a PAPA-like syndrome in which cutaneous manifestation, such as pyoderma gangrenosum and acne fulminans, predominated. Sequencing of the PSTPIP1 gene was performed in the patient and his extended family. The patient was treated with canakinumab.
Roujeau et al evaluate the incidence, type, and severity of telaprevir-associated skin reactions. Data from 3 international phase 3 studies of telaprevir in combination with interferon and ribavirin.
Silverberg and Silverberg undertook a prospective questionnaire-based study of whether the extent, distribution, and duration of vitiligo are associated with quality-of-life impairment.
Paller et al conducted an international study to evaluate the association between adiposity and the severity of psoriasis in children.
Belkin and colleagues characterize the presence of CD200 and CD200 receptor in cutaneous squamous cell carcinoma (SCC) microenvironment and propose a role for the CD200 axis in immune evasion by SCC.